ClinicalTrials.Veeva

Menu

Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)

Masimo logo

Masimo

Status

Enrolling

Conditions

Hypoxemia

Treatments

Device: RD SET Sensor

Study type

Interventional

Funder types

Industry

Identifiers

NCT06432881
GOOD0001

Details and patient eligibility

About

The objective of this study is to evaluate the performance of Masimo RD SET® SpO2 sensors in subjects with light and dark skin pigmentation in the intensive care therapeutic area.

Enrollment

152 estimated patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject is 18 years of age or older.
  • Subject is receiving care in an intensive care unit.
  • Subject with an arterial catheter in place.
  • Subject is experiencing hypoxemia as defined by 1) need for supplement oxygen or 2) peripheral oxygenation ≤ 94% on room air

Exclusion criteria

  • Subjects in whom pulse oximetry cannot be reliably performed on both the third and fourth digit on the hand ipsilateral to the arterial line, precluding application of the sensor (e.g., amputation and deformity).
  • Subjects with a skin condition affecting the digits, where the sensor is applied, which would preclude sensor placement as standard of care (e.g., psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown, etc.).
  • Subjects with distinct geographic variances in skin pigmentation (e.g., vitiligo) on the digit where the sensor is applied, which would preclude sensor placement as standard of care.
  • Subjects with nail polish or acrylic nails on the digits where sensor needs to be applied.
  • Subjects with known allergic reactions to adhesive tapes.
  • Subjects with arterial catheter placed in a lower extremity.
  • Subjects not suitable for the investigation at the discretion of the investigator or the clinical team.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Sequential Assignment

Masking

None (Open label)

152 participants in 1 patient group

RD SET Sensor
Experimental group
Description:
All subjects are enrolled into this arm and will have Sp02 measurements obtained.
Treatment:
Device: RD SET Sensor

Trial contacts and locations

1

Loading...

Central trial contact

Chelsea Frank

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems